Filing Flows › Decoy Therapeutics (DCOY) › Stock forecast & fair value
Decoy Therapeutics (DCOY) stock forecast and price target
Decoy Therapeutics (DCOY) trades at $1.13. One analyst's price target is $3.00 (+166%).
Decoy Therapeutics' latest quarter
Decoy Therapeutics, Q2 2026: revenue $228K, net loss $2.4M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for DCOY stock?
One analyst's 12-month target is $3.00, +166% from $1.13. The average rating is none.
Does Decoy Therapeutics usually beat earnings estimates?
It beat the consensus EPS estimate in 50% of the quarters on record.
Is DCOY stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.